Bacon v. Stiefel Laboratories, Inc.

714 F. Supp. 2d 1186, 49 Employee Benefits Cas. (BNA) 2308, 2010 U.S. Dist. LEXIS 55784, 2010 WL 2164566
District Court, S.D. Florida·Decided May 27, 2010·No. Case 09-21871-CV·Published·Cited by 1 cases

Opinion

ORDER ON MOTIONS TO DISMISS

JAMES LAWRENCE KING, District Judge.

THIS CAUSE comes before the Court upon two motions to dismiss. One was filed by Stiefel Laboratories, Inc., Charles W. Stiefel, Brent D. Stiefel, Todd Stiefel, Lodewijk de Vink, Steve Karasick, Michael Cornelius, and Matt S. Pattullo (collectively, the “Stiefel Defendants”) (DE # 50), and one was filed by Terrence N. Bogush and Bogush & Grady, LLP (collectively, the “Bogush Defendants”) (DE # 51). Plaintiffs have filed Responses (DE # 57 & 58), and both sets of Defendants have filed Replies (DE # 66 & 65).

The factual allegations in the Amended Complaint (DE # 47) are substantially the same as those set forth in the original Complaint, and those allegations are summarized in the Court’s Order Granting Motions to Dismiss in Part (DE # 43). The instant Motions to Dismiss are directed at the Amended Complaint, and the Court will address each motion in turn. 1

*1190 I. The Stiefel Defendants’ Motion to Dismiss

The Stiefel Defendants’ first argument is that Plaintiffs lack standing to bring their ERISA claims. Claims under ERISA § 502(a) may be brought only by “participants,” “fiduciaries,” beneficiaries,” and the Secretary of Labor. 29 U.S.C. § 1132(a). Participant is defined as “any employee or former employee ... who is or may become eligible to receive a benefit of any type from an employee benefit plan.” 29 U.S.C. § 1002(7). Thus, the Stiefel Defendants argue that Plaintiffs are not “participants” because they are no longer eligible to receive Plan benefits. This argument does not have merit. In Lanfear v. Home Depot, Inc., 536 F.3d 1217, 1222 (11th Cir.2008), the Eleventh Circuit squarely addressed this issue, holding that “[a] complaint for the decrease in value of a defined contribution account due to a breach of fiduciary duty is not for damages because it is limited to the difference between the benefits actually received and the benefits that would have been received if the plan management had fulfilled its statutory obligations. Because their complaint is for benefits, not damages, the former employees qualify as participants.” That is precisely the case here: Former employees are seeking the true value of them ERISA benefits, which is the fair market value of their company stock. See also LaRue v. DeWolff, Boberg & Assocs., 552 U.S. 248, 256 n. 6,128 S.Ct. 1020, 169 L.Ed.2d 847 (2008) (“A plan ‘participant,’ as defined by § 3(7) of ERISA, 29 U.S.C. § 1002(7), may include a former employee with a colorable claim for benefits.”). Thus, Plaintiffs qualify as participants.

The Stiefel Defendants’ next argument is that ERISA § 502(a)(2) only authorizes relief on behalf of an ERISA Plan itself, and does not provide a basis for personal monetary recovery. While this may have been true before LaRue, the Supreme Court has recently held that, when examining the ERISA text as a whole, a participant may sue for fiduciary breaches that affect the value of Plan assets in an individual’s account. LaRue, 552 U.S. at 256, 128 S.Ct. 1020 (“We therefore hold that although § 502(a)(2) does not provide a remedy for individual injuries distinct from plan injuries, that provision does authorize recovery for fiduciary breaches that impair the value of plan assets in a participant’s individual account.”). Thus, Defendants are not entitled to dismissal on this basis.

Next, the Stiefel Defendants argue that ERISA § 502(a)(3) only authorizes traditional forms of equitable relief, such as injunctions and restitution, and does not provided for monetary damages. This argument is premature, and may be addressed at a later stage in this litigation, such as summary judgment. At this point, it would be inappropriate for the Court to sort through Plaintiffs’ counts to determine which ones authorize certain types of relief.

The Stiefel Defendants’ next argument is that Plaintiffs have not pled sufficient facts showing that an ERISA prohibited transaction occurred. ERISA defines a “prohibited transaction” as, inter alia, a transaction between an ERISA plan and a “party in interest.” 29 U.S.C. § 1106(a). Thus, the Stiefel Defendants argue that the transaction at issue was between Plain *1191 tiffs and Stiefel Laboratories, Inc. (“the Company”), neither of which is the ERISA Plan. However, the documents in the record regarding the transaction at issue show that Plaintiff Palakovieh appointed the Plan to act as his agent to effectuate the sale of the stock. See DE # 50-1. Thus, this was a transaction between the Plan and the Company, and the individual plaintiffs merely needed to authorize the selling of the shares that they “owned” but were held by the Plan. Therefore, Plaintiffs have alleged sufficient facts to assert a prohibited transaction under ERISA. 2

Next, the Stiefel Defendants argue that Plaintiffs have failed to state a claim for breach of ERISA fiduciary duties because there is no duty under ERISA to disclose corporate events that would affect the price of the stock. This is essentially the same argument that Defendants made in seeking dismissal of the securities fraud count. The Court rejects that argument for the same reasons: Although ordinarily ERISA fiduciaries, just like corporate directors, have no duty to disclose merger discussions, when those fiduciaries send communications to shareholders reporting the price of the stock while knowing that the price is probably inaccurate, such merger discussions constitute material information that must be disclosed. Defendants’ reliance on Ervast v. Flexible Prods. Co., 346 F.3d 1007 (11th Cir.2003), is misplaced. Ervast did not hold that directors are not required to disclose merger discussions. Moreover, in Ervast the plaintiff did not claim that his stock was valued incorrectly, he claimed that information about merger discussions would have affected his decision on when to retire, Therefore, Plaintiffs have adequately pled that defendants breached their fiduciary duties by failing to disclose material information which affected the fair market value of the stock — i.e., the benefit due to Plaintiffs under the Plan.

The Stiefel Defendants’ next argument is that Plaintiffs have failed to state a claim for breach of ERISA fiduciary duties against the director defendants. That is, they argue that the directors merely appoint the ERISA fiduciaries, their duties are limited to monitoring the ERISA fiduciaries, and Plaintiffs have not pled any facts showing they were aware of wrongdoing but failed to correct it.

Free access — add to your briefcase to read the full text and ask questions with AI

Bacon v. Stiefel Laboratories, Inc., 714 F. Supp. 2d 1186, 49 Employee Benefits Cas. (BNA) 2308, 2010 U.S. Dist. LEXIS 55784, 2010 WL 2164566 (S.D. Fla. 2010).

714 F. Supp. 2d 1186 (Bacon v. Stiefel Laboratories, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Clark v. Cascio
M.D. Florida, 2022